Not applicableLooking for participantsNCT06214689What this trial is testingIDH1 and OCT4 in High Grade AstrocytomaWho this might be right forHigh Grade Astrocytoma Assiut University 35
Testing effectiveness (Phase 2)Ended earlyNCT01068782What this trial is testingMultiple Doses and Regimens of Cabozantinib in Subjects With Grade IV Astrocytic Tumors in First or Second RelapseWho this might be right forAstrocytic Tumors Exelixis 19
Early research (Phase 1)Study completedNCT00960492What this trial is testingSafety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With GlioblastomaWho this might be right forGlioblastomaGiant Cell GlioblastomaGliosarcoma Exelixis 26
Testing effectiveness (Phase 2)Study completedNCT01837862What this trial is testingA Phase I Study of Mebendazole for the Treatment of Pediatric GliomasWho this might be right forPilomyxoid AstrocytomaPilocytic AstrocytomaGlioma, Astrocytic+9 more Julie Krystal 36
Large-scale testing (Phase 3)Study completedNCT00052455What this trial is testingTemozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant GliomaWho this might be right forBrain and Central Nervous System Tumors Institute of Cancer Research, United Kingdom 500
Testing effectiveness (Phase 2)Looking for participantsNCT04923126What this trial is testingSJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade GliomaWho this might be right forLow-Grade GliomaRecurrent Low-Grade GliomaProgressive Low-Grade Glioma St. Jude Children's Research Hospital 132
Not applicableStudy completedNCT06620926What this trial is testingImpact of IDH Mutation and Adjuvant Chemo(radio)therapy on Survival Outcome in Grade II/III AstrocytomaWho this might be right forAstrocytomaAstrocytic TumorsAstrocytoma of Brain asmaa salama ibrahim 811
Testing effectiveness (Phase 2)Looking for participantsNCT05465954What this trial is testingEfineptakin Alfa and Pembrolizumab for the Treatment of Recurrent GlioblastomaWho this might be right forHigh Grade Astrocytic TumorRecurrent Glioblastoma, IDH-WildtypeRecurrent Gliosarcoma Mayo Clinic 54
Early research (Phase 1)Ended earlyNCT02924038What this trial is testingVarlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)Who this might be right forGliomaMalignant GliomaAstrocytoma, Grade II+3 more Nicholas Butowski 14
Not applicableLooking for participantsNCT06572475What this trial is testingUSPIO Enhanced MR Imaging in CNS Tumours (UMIC)Who this might be right forVestibular SchwannomaGlioma, Astrocytic Northern Care Alliance NHS Foundation Trust 17
Not applicableLooking for participantsNCT06878469What this trial is testingSIMPLIFication of Care Pathways for Patients With Rare Brain Tumors Through Artificial IntelligenceWho this might be right forBrain Tumors Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 200
Not applicableLooking for participantsNCT05532397What this trial is testingEvaluation of ex Vivo Drug Combination Optimization Platform in Recurrent High Grade Astrocytic GliomaWho this might be right forGlioma, Astrocytic National University Hospital, Singapore 10
Not applicableStudy completedNCT00890435What this trial is testingDecision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical TrialWho this might be right forBrain and Central Nervous System TumorsLeukemiaUnspecified Adult Solid Tumor, Protocol Specific+1 more Children's Oncology Group 53
Testing effectiveness (Phase 2)UnknownNCT00313521What this trial is testingThiotepa and Radiation Therapy in Treating Young Patients With Newly Diagnosed Malignant Brain TumorsWho this might be right forBrain and Central Nervous System Tumors Children's Cancer and Leukaemia Group 30
Not applicableUnknownNCT00757614What this trial is testingStudy of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United KingdomWho this might be right forBladder CancerBrain and Central Nervous System TumorsEsophageal Cancer+6 more Cancer Research UK 14,000
Early research (Phase 1)Study completedNCT02549833What this trial is testingNeo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II GliomaWho this might be right forOligodendrogliomaAstrocytoma, Grade IIGlioma, Astrocytic+3 more Jennie Taylor 28
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Looking for participantsNCT06776250What this trial is testingStudy of How Safe and Effective Tarlatamab is in Brain CancersWho this might be right forAstrocytic TumorOligodendroglial Tumor University Health Network, Toronto 44
Early research (Phase 1)Study completedNCT01967758What this trial is testingPhase I Study of Safety and Immunogenicity of ADU-623Who this might be right forAstrocytic TumorsGlioblastoma MultiformeAnaplastic Astrocytoma+1 more Providence Health & Services 11
Testing effectiveness (Phase 2)Ended earlyNCT05267106What this trial is testingStudy to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 AlterationsWho this might be right forGlioblastomaAdult-type Diffuse Gliomas Incyte Corporation 83